Join to View Full Profile
120 N Eagle Creek DrSte 500Lexington, KY 40509
Phone+1 859-263-3900
Fax+1 859-263-3757
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 1 invite waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. John Kitchens, MD is a board certified ophthalmologist in Lexington, Kentucky. He is currently licensed to practice medicine in Kentucky, Indiana, and West Virginia.
Education & Training
University of Iowa Hospitals and ClinicsResidency, Ophthalmology, 2000 - 2003
Indiana University School of Medicine/Methodist HospitalInternship, Transitional Year, 1999 - 2000- Indiana University School of MedicineClass of 1999
Certifications & Licensure
KY State Medical License 2005 - 2026
IN State Medical License 2017 - 2025
WV State Medical License 2013 - 2014
FL State Medical License 2003 - 2011
IA State Medical License 2000 - 2004
American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- Tractional Retinal Detachment in a Patient With a History of Methamphetamine Use.Angela J Kim, Omar Sabbagh, Osama Sabbagh, Michelle Abou-Jaoude, John W Kitchens
Journal of Vitreoretinal Diseases. 2025-02-15 - Fluocinolone acetonide 0.18-mg implant for treatment of recurrent inflammation due to non-infectious uveitis: a case series of 15 patients.Robert A Sisk, Daniel F Kiernan, David Almeida, Anton M Kolomeyer, David Eichenbaum
Journal of Ophthalmic Inflammation and Infection. 2024-09-19 - ANATOMICAL AND FUNCTIONAL OUTCOMES OF BEVACIZUMAB TREATMENT IN PEDIATRIC AUTOSOMAL RECESSIVE BESTROPHINOPATHY.Mitchell Jacobs, May El-Rashedy, Nicholas Fowler, Belinda Shirkey, John Kitchens
Retinal Cases & Brief Reports. 2024-05-01
Press Mentions
Roche Susvimo Maintains Vision over Five Years with Two Refills Per Year in People with nAMDAugust 3rd, 2025- Genentech Unveils Five-Year Data for Susvimo: Long-Term Efficacy and Durability in Wet AMD TreatmentApril 8th, 2025
- RWC Update: Artificial Intelligence and Smart Eyewearables for Healthy Longevity; Choroidal Hemangioma Widefield Optical Coherence TomographyFebruary 1st, 2023
- Join now to see all
